Home >> Business >> Breast Biopsy Devices Market Is Expected To Reach US$ 1,907.5 Mn By 2026 | Credence Research

Breast Biopsy Devices Market Is Expected To Reach US$ 1,907.5 Mn By 2026 | Credence Research

The latest market report published by Credence Research, Inc. “Breast Biopsy Devices Market By Biopsy Type (Fine Needle Aspiration Biopsy (FNAB), Core Needle Biopsy (CNB), Vacuum Assisted Breast Biopsy (VABB), Incisional And Excisional Breast Biopsy) By Products (Needle Based Biopsy Guns, Biopsy Guidance Systems, Biopsy Forceps, Biopsy Needles, Others) By Guidance Modality (Stereotactic X-ray Guided Biopsy, Ultrasound Guided Biopsy, Mri Guided Biopsy, Without Imaging Guidance Biopsy) – Growth, Future Prospects, Competitive Analysis, 2018 – 2026,” the global breast biopsy devices market was valued at US$ 781.3 Mn in 2017 and expected to reach US$ 1,907.5 Mn by 2026, expanding at a CAGR of 10.3% from 2018 to 2026.

Browse the full report at “Breast Biopsy Devices Market

Market Insights

Growing incidence of breast cancer and related screening programmes, along with increasing demand for minimally invasive procedures are driving the growth of the global breast biopsy devices market. With gradual replacement of open surgical biopsies with non-invasive fine needle and stereotactic biopsies the global biopsy devices market has gained momentum over the years. Among the various biopsy types, vacuum assisted biopsy devices segment currently holds the largest market share due to its proven efficacy and precision in tissue sample extraction and less pain caused to the patients. Versatility of these devices for use under sonography, mammography, and MRI makes this device further accepted in the global market.

Among the considered imaging modalities, the global breast biopsy devices market is dominated by stereotactic x-ray guidance, as this is among the first introduced in the market. This has led to widespread presence of the guidance system globally and therefore leading to largest revenue share. MRI due to its better precision is anticipated to be the fastest progressing guidance modality during the forecast period. Similarly, among the product and device types used for performing breast biopsy, the demand for guidance systems is estimated to be the highest. Burgeoning demand for guidance systems in developing markets of Asia Pacific and Latin America, and growing replacement of conventional devices with the advanced MRI guidance systems are attributed to the prominent position of this segment.

Geographically, North America is the leading regional market for breast biopsy devices. Greater awareness, presence of better reimbursements, and evolved healthcare infrastructure are the key attributes for the dominance of North America market. On the other hand, Asia Pacific is anticipated to be the fastest advancing market for breast biopsy devices. Expanding healthcare sector, growing adoption of newly developed technologies, increasing incidence of breast cancer and rapid proliferation of medical tourism industry will contribute to the swift progress of Asia Pacific market.

Download Free PDF Sample Request: Breast Biopsy Devices Market

As the technological front of breast biopsy devices is rapidly advancing, the market players are continuously striving to introduce their latest products to the market. Furthermore, they are also initiating efforts to introduce their best selling products in the emerging and untapped markets. Some of the key players operating in the global breast biopsy devices market are Hologic, Becton, Dickinson and Company, C.R. Bard, Inc., Mammotome (Devicor Medical Products, Inc.), Aurora Imaging Technology, Inc. and Planmed OY.

By Biopsy Type (2016–2026; US$ Mn)

  • Fine Needle Aspiration Biopsy (FNAB)
  • Core Needle Biopsy (CNB)
  • Vacuum Assisted Breast Biopsy (VABB)
  • Incisional and Excisional Breast Biopsy

By Product (2016–2026; US$ Mn)

  • Needle Based Biopsy Guns
  • Biopsy Guidance Systems
  • Biopsy Forceps
  • Biopsy Needles
  • Others (Curettes, Punches, Markers)

By Guidance Modality (2016–2026; US$ Mn)

  • Stereotactic X-ray Guided Biopsy
  • Ultrasound Guided Biopsy
  • MRI Guided Biopsy
  • Without Imaging Guidance Biopsy

By Geography Segment (2016–2026; US$ Mn)

  • North America
  • Europe
  • Asia Pacific (APAC)
  • Middle East & Africa (MEA)
  • Latin America

Download Free PDF Sample Request: Breast Biopsy Devices Market

About Us

Credence Research is a worldwide market research and counseling firm that serves driving organizations, governments, non-legislative associations, and not-for-benefits. We offer our customers some assistance with making enduring enhancements to their execution and understand their most imperative objectives. Over almost a century, we’ve manufactured a firm extraordinarily prepared to this task.

Media Contact

Name: Chris Smith

Address: 105 N 1st ST #429,

SAN JOSE, CA 95103 US

Toll-Free (US/CANADA) Ph.: +1-800-361-8290

E-mail: sales@credenceresearch.com

Website: http://www.credenceresearch.com

Leave a Reply

Your email address will not be published. Required fields are marked *